Patents Assigned to GEN1E LIFESCIENCES INC.
  • Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors
    Patent number: 11976049
    Abstract: Substituted naphthyl p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38? mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
    Type: Grant
    Filed: December 5, 2022
    Date of Patent: May 7, 2024
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • P38? mitogen-activated protein kinase inhibitors
    Patent number: 11926635
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: March 12, 2024
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • Substituted naphthyl p38? mitogen-activated protein kinase inhibitors
    Patent number: 11555020
    Abstract: Substituted naphthyl p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38? mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: January 17, 2023
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • p38? mitogen-activated protein kinase inhibitors
    Patent number: 11440918
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: September 13, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate
    Patent number: 11390581
    Abstract: Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide dihydrochloride dihydrate, methods of preparing the crystalline salt, pharmaceutical compositions containing the crystalline salt, and methods of treatment using the crystalline salt are disclosed.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: July 19, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Ritu Lal, Wendy Luo
  • P38? mitogen-activated protein kinase inhibitors
    Patent number: 11286260
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: March 29, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal